PorA VR3 Typing Database: A web-based resource for the determination of PorA VR3 alleles of Neisseria meningitidis

Infection, Genetics and Evolution

Volumn 11, Issue 1, 2011, Pages 248-249

  De Filippis, Ivano ^a   Gopalan, Vivek ^b   Huyen, Yentram ^b  

^a Oswaldo Cruz Foundation   (Brazil)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Neisseria meningitidis; PorA; Variable regions; VR3 database

Indexed keywords

PORIN A;

ALLELE; ARTICLE; CONTROLLED STUDY; GENETIC DATABASE; GENETIC IDENTIFICATION; GENETIC VARIABILITY; GENOTYPE; INTERNET; NEISSERIA MENINGITIDIS; NOMENCLATURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS;

ALLELES; DATABASES, GENETIC; INTERNET; NEISSERIA MENINGITIDIS; PORINS;

NEISSERIA MENINGITIDIS;

EID: 78650183445     PISSN: 15671348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meegid.2010.08.011     Document Type: Article

References (10)

1. Arhin F.F., Moreau F., Coulton J.W., Mills E.L. Sequencing of porA from clinical isolates of Neisseria meningitidis defines a subtyping scheme and its genetic regulation. Can. J. Microbiol. 1998, 44:56-63.
2. Clarke S.C., Diggle M.A., Mölling P., Unemo M., Olcén P. Analysis of PorA variable region 3 in meningococci: implications for vaccine policy?. Vaccine 2003, 21:2468-2473.
3. de Filippis I., de Andrade C.F., Silva L., Prevots D.R., Vicente A.C. PorA variable antigenic regions VR1, VR2, and VR3 of Neisseria meningitidis serogroups B and C isolated in Brazil from 1999 to 2004. Infect. Immun. 2007, 75:3683-3685.
4. Diggle M.A., Clarke S.C. Detection and genotyping of meningococci using a nested PCR approach. J. Med. Microbiol. 2003, 52:51-57.
5. Fazio C., Starnino S., Dal Solda M., Sofia T., Néri A., Mastrantonio P., Stefanelli P. Neisseria meningitidis serogroup×sequence type 2888, Italy. Emerg. Infect. Dis. 2010, 16:348-349.
6. Molling P., Unemo M., Backman A., Olcen P. Genosubtyping by sequencing group A, B and C meningococci; a tool for epidemiological studies of epidemics, clusters and sporadic cases. APMIS 2000, 108:509-516.
7. Oomen C.J., Hoogerhout P., Bonvin A.M., Kuipers B., Brugghe H., Timmermans H., Haseley S.R., van Alphen L., Gros P. Immunogenicity of peptide-vaccine candidates predicted by molecular dynamics simulations. J. Mol. Biol. 2003, 328:1083-1089.
8. Stefanelli P., Fazio C., Sofia T., Neri A., Mastrantonio P. Serogroup C meningococci in Italy in the era of conjugate menC vaccination. BMC Infect. Dis. 2009, 9:135.
9. Suker J., Feavers I.M., Achtman M., Morelli G., Wang J.F., Maiden M.C. The porA gene in serogroup A meningococci: evolutionary stability and mechanism of genetic variation. Mol. Microbiol. 1994, 12:253-265.
10. Vermont C.L., van den Dobbelsteen G.P. Meningococcal serogroup B infections: a search for a broadly protective vaccine. Expert Rev. Vaccines 2003, 2:673-681.